Balyasny Asset Management
TIL icon

Balyasny Asset Management’s Instil Bio TIL Stock Holding History

Balyasny Asset Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-88,796
Closed -$1.85M – 3468
2025
Q2 		$1.85M Sell
88,796
-228,528
-72% -$4.78M ﹤0.01% 1774
2025
Q1 		$5.51M Buy
317,324
+255,691
+415% +$5.3M 0.01% 1201
2024
Q4 		$1.18M Buy
61,633
+44,411
+258% +$1.35M ﹤0.01% 1878
2024
Q3 		$1.16M Buy
+17,222
New +$405K ﹤0.01% 1904
2023
Q3 		– Sell
-823
Closed -$9.07K – 2732
2023
Q2 		$9.07K Buy
+823
New +$10.1K ﹤0.01% 2181
2021
Q4 		– Sell
-1,319
Closed -$472K – 2591
2021
Q3 		$472K Buy
+1,319
New +$492K ﹤0.01% 1496

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balyasny Asset Management's TIL Position: Q3 2025 in Review

Balyasny Asset Management sold out of Instil Bio (TIL) in Q3 2025, closing a stake of 88,796 shares — an estimated $1.85M sold.

Balyasny Asset Management first reported a position in TIL in Q3 2021 and held it in 6 quarters. The position peaked at $5.51M in Q1 2025. 34 funds tracked by Wall St. Rank hold TIL as of Q3 2025.

  • Balyasny Asset Management reported no remaining Instil Bio position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 88,796 Instil Bio shares in Q3 2025, an estimated $1.85M.
  • Balyasny Asset Management first reported a position in Instil Bio in Q3 2021 and held it in 6 quarters.
  • Balyasny Asset Management's Instil Bio position peaked at $5.51M in Q1 2025.
  • 34 funds tracked by Wall St. Rank held Instil Bio as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.